Cargando…
Galectin‐9 and myeloid‐derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia
BACKGROUND: Galectin‐9 and myeloid‐derived suppressor cells (MDSCs) have an important role in tumors, but their clinical values in chronic lymphocytic leukemia (CLL) have not been fully elucidated. This study aimed to analyze the prognosis values of Galectin‐9 and MDSCs in CLL. METHODS: The concentr...
Autores principales: | Alimu, Xierenguli, Zhang, Juan, Pang, Nannan, Zhang, Rui, Chen, Rong, Zeng, Xuejiao, Tudahong, Shabaaiti, Chen, Gang, Muhashi, Maliya, Zhao, Fang, Ding, Jianbing, Qu, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165952/ https://www.ncbi.nlm.nih.gov/pubmed/37249287 http://dx.doi.org/10.1002/iid3.853 |
Ejemplares similares
-
Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015) -
Immunomodulatory effects of galectin-1 in patients with chronic lymphocytic leukemia
por: Kostic, Milos, et al.
Publicado: (2021) -
Identification of galectin-1 as a novel mediator for chemoresistance in chronic myeloid leukemia cells
por: Luo, Wu, et al.
Publicado: (2016) -
Galectin-9: A Suppressor of Atherosclerosis?
por: Yu, Jian, et al.
Publicado: (2020) -
Increased serum levels of Galectin-9 in patients with chronic lymphocytic leukemia
por: Wdowiak, Kamil, et al.
Publicado: (2019)